The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity
Abstract
Accumulating evidence has suggested a role for p53 activation in various age-associated conditions. Here, we identified a crucial role of endothelial p53 activation in the regulation of glucose homeostasis. Endothelial expression of p53 was markedly upregulated when mice were fed a high-calorie diet. Disruption of endothelial p53 activation improved dietary inactivation of endothelial nitric oxide synthase that upregulated the expression of peroxisome proliferator-activated receptor-γ coactivator-1α in skeletal muscle, thereby increasing mitochondrial biogenesis and oxygen consumption. Mice with endothelial cell-specific p53 deficiency fed a high-calorie diet showed improvement of insulin sensitivity and less fat accumulation, compared with control littermates. Conversely, upregulation of endothelial p53 caused metabolic abnormalities. These results indicate that inhibition of endothelial p53 could be a novel therapeutic target to block the vicious cycle of cardiovascular and metabolic abnormalities associated with obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cell-specific p53 deficiency can improve insulin sensitivity and decrease fat accumulation to relieve the occurrence and development of obesity.271”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [271]
In the citing paper
“Feeding endothelial cell-specific inactivated mice a high-calorie diet improved insulin resistance and decreased fat accumulation,271”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [271]
In the citing paper
“suggesting that the suppression of endothelial p53 could be a new target for the treatment of obese patients with metabolic abnormalities.”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [271]
In the citing paper
“The inhibition of endothelial p53 activation facilitates oxygen consumption and mitochondrial biogenesis by inhibiting the inactivation of endothelial nitric oxide synthase.271”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [271]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
Arany, Z., Foo, S.-Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M., et al. (2008) · Nature · doi:10.1038/nature06613 · Cited by 1,054
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., Kelly, D. P., & Spiegelman, B. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061035098 · Cited by 663
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Self-citationEssential role of limiting telomeres in the pathogenesis of Werner syndrome
Chang, S., Multani, A. S., Cabrera, N. G., Naylor, M. L., Laud, P., Lombard, D., Pathak, S., Guarente, L., & DePinho, R. A. (2004) · Nature Genetics · doi:10.1038/ng1389 · Cited by 462
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Research works printed but not linked: 48
- Aguilar, 2007, S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase, Cell Metab., 5, 476, 10.1016/j.cmet.2007.05.006 · DOI · Paper page
- Alpert, 2005, Delayed autoregulation of glucose transport in vascular endothelial cells, Diabetologia, 48, 752, 10.1007/s00125-005-1681-y · DOI
- Arany, 2008, PGC-1 coactivators and skeletal muscle adaptations in health and disease, Curr. Opin. Genet. Dev., 18, 426, 10.1016/j.gde.2008.07.018 · DOI · Paper page
- Barber, 2004, Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes, Stroke, 35, 1720, 10.1161/01.STR.0000129653.22241.d7 · DOI
- Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570 · DOI · Paper page
- Benedito, 2009, The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis, Cell, 137, 1124, 10.1016/j.cell.2009.03.025 · DOI · Paper page
- Brodsky, 2004, Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen, Circ. Res., 94, 377, 10.1161/01.RES.0000111802.09964.EF · DOI · Paper page
- Butler, 2010, A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes, Diabetes, 59, 323, 10.2337/db09-1471 · DOI · Paper page
- Calvo, 2008, Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake, J. Appl. Physiol., 104, 1304, 10.1152/japplphysiol.01231.2007 · DOI · Paper page
- Cantley, 1999, New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway, Proc. Natl. Acad. Sci. USA, 96, 4240, 10.1073/pnas.96.8.4240 · DOI · Paper page
- Cao, 2013, Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity, Cell Metab., 18, 478, 10.1016/j.cmet.2013.08.008 · DOI · Paper page
- Chen, 2006, Premature senescence of endothelial cells: Methusaleh’s dilemma, Am. J. Physiol. Heart Circ. Physiol., 290, H1729, 10.1152/ajpheart.01103.2005 · DOI
- Clark, 2008, Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle, Am. J. Physiol. Endocrinol. Metab., 295, E732, 10.1152/ajpendo.90477.2008 · DOI · Paper page
- Clark, 2003, Blood flow and muscle metabolism: a focus on insulin action, Am. J. Physiol. Endocrinol. Metab., 284, E241, 10.1152/ajpendo.00408.2002 · DOI · Paper page
- Claxton, 2008, Efficient, inducible Cre-recombinase activation in vascular endothelium, Genesis, 46, 74, 10.1002/dvg.20367 · DOI · Paper page
- Cousin, 2001, Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1, Endocrinology, 142, 229, 10.1210/endo.142.1.7863 · DOI · Paper page
- Czernichow, 2010, Microvascular dysfunction in healthy insulin-sensitive overweight individuals, J. Hypertens., 28, 325, 10.1097/HJH.0b013e328333d1fc · DOI · Paper page
- Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 · DOI · Paper page
- Huang, 2012, Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function, Proc. Natl. Acad. Sci. USA, 109, 17478, 10.1073/pnas.1209281109 · DOI
- Jonk, 2007, Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension, Physiology (Bethesda), 22, 252
- Kawase, 2009, PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt, Cell, 136, 535, 10.1016/j.cell.2008.12.002 · DOI · Paper page
- Kim, 2005, Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism, Mol. Cell. Biol., 25, 9713, 10.1128/MCB.25.21.9713-9723.2005 · DOI
- Kim, 2008, p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc, Circ. Res., 103, 1441, 10.1161/CIRCRESAHA.108.181644 · DOI
- Kukreja, 2007, eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?, J. Mol. Cell. Cardiol., 42, 280, 10.1016/j.yjmcc.2006.10.011 · DOI
- Kumar, 2011, p53 impairs endothelial function by transcriptionally repressing Kruppel-Like Factor 2, Arterioscler. Thromb. Vasc. Biol., 31, 133, 10.1161/ATVBAHA.110.215061 · DOI
- Kunieda, 2006, Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway, Circulation, 114, 953, 10.1161/CIRCULATIONAHA.106.626606 · DOI · Paper page
- Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat. Med., 8, 731, 10.1038/nm724 · DOI · Paper page
- Marino, 2000, Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum, Genes Dev., 14, 994, 10.1101/gad.14.8.994 · DOI · Paper page
- McTernan, 2003, Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes, J. Clin. Endocrinol. Metab., 88, 6098, 10.1210/jc.2003-030898 · DOI · Paper page
- Minamino, 2008, Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes, Nat. Clin. Pract. Cardiovasc. Med., 5, 637, 10.1038/ncpcardio1324 · DOI
- Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
- Miyauchi, 2004, Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway, EMBO J., 23, 212, 10.1038/sj.emboj.7600045 · DOI · Paper page
- Montooth, 2003, Mapping determinants of variation in energy metabolism, respiration and flight in Drosophila, Genetics, 165, 623, 10.1093/genetics/165.2.623 · DOI
- Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180 · DOI · Paper page
- Mortensen, 1999, Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53, J. Biol. Chem., 274, 37679, 10.1074/jbc.274.53.37679 · DOI
- Muris, 2012, Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis, Arterioscler. Thromb. Vasc. Biol., 32, 3082, 10.1161/ATVBAHA.112.300291 · DOI
- Oike, 2005, Angiopoietin-related growth factor antagonizes obesity and insulin resistance, Nat. Med., 11, 400, 10.1038/nm1214 · DOI · Paper page
- Orimo, 2009, Protective role of SIRT1 in diabetic vascular dysfunction, Arterioscler. Thromb. Vasc. Biol., 29, 889, 10.1161/ATVBAHA.109.185694 · DOI · Paper page
- Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. USA, 100, 8466, 10.1073/pnas.1032913100 · DOI · Paper page
- Plutzky, 2011, Macrovascular effects and safety issues of therapies for type 2 diabetes, Am. J. Cardiol., 108, 25B, 10.1016/j.amjcard.2011.03.014 · DOI
- Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5 · DOI · Paper page
- Rajah, 2001, Differential glucose uptake in retina- and brain-derived endothelial cells, Microvasc. Res., 62, 236, 10.1006/mvre.2001.2337 · DOI
- Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
- Serrano, 2001, Putting the stress on senescence, Curr. Opin. Cell Biol., 13, 748, 10.1016/S0955-0674(00)00278-7 · DOI · Paper page
- Stambolic, 2001, Regulation of PTEN transcription by p53, Mol. Cell, 8, 317, 10.1016/S1097-2765(01)00323-9 · DOI · Paper page
- Stewart, 2006, Telomeres: cancer to human aging, Annu. Rev. Cell Dev. Biol., 22, 531, 10.1146/annurev.cellbio.22.010305.104518 · DOI · Paper page
- Tang, 2010, The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells, Genesis, 48, 563, 10.1002/dvg.20654 · DOI · Paper page
- Vicent, 2003, The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance, J. Clin. Invest., 111, 1373, 10.1172/JCI15211 · DOI · Paper page
Cited by
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495
Understanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Obesity and related consequences to ageing
Jura, M., & Kozak, L. P. (2016) · AGE · doi:10.1007/s11357-016-9884-3 · Cited by 473
Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
DNA damage response and metabolic disease
Shimizu, I., Yoshida, Y., Suda, M., & Minamino, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.008 · Cited by 286
Self-citation
Metadata
- Authors
- Yokoyama, M., Okada, S., Nakagomi, A., Moriya, J., Shimizu, I., Nojima, A., Yoshida, Y., Ichimiya, H., Kamimura, N., Kobayashi, Y., Ohta, S., Fruttiger, M., Lozano, G., & Minamino, T.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 7
- Issue
- 5
- Pages
- 1691-1703
- ISSN
- 2211-1247
- Cited by
- 121
- References
- 15
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Funders
- Takeda Science Foundation
- SENSHIN Medical Research Foundation
- Uehara Memorial Foundation
- NOVARTIS Foundation (Japan) for the Promotion of Science
- Ministry of Education
- Japan Diabetes Foundation
- Daiichi Sankyo Foundation of Life Science
- Life Science Foundation of Japan
- Naito Foundation
- Ono Medical Research Foundation
- Takeda Medical Research Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity. https://app.cochat.ai/papers/10.1016/j.celrep.2014.04.046
- The paper
- Yokoyama, M., Okada, S., Nakagomi, A., Moriya, J., Shimizu, I., Nojima, A., Yoshida, Y., Ichimiya, H., Kamimura, N., Kobayashi, Y., Ohta, S., Fruttiger, M., Lozano, G., & Minamino, T. (2014). Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity. Cell Reports. https://doi.org/10.1016/j.celrep.2014.04.046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.